Combining oxygen delivery and generation for targeted atherosclerosis therapy

Yujie Wang, Qun Zhou, Le Lü, Jianhua Xu, Gang Yang, Xuan Sun, Xue Bao, Lina Kang, Pin Lv, Renyuan Liu, Biao Xu, Qi Yang, Dan Mu, Bing ZhangJournal of Controlled Release 2025 · DOI

Abstract

Hypoxia plays an important role in the progression of atherosclerosis. However, ameliorating hypoxia at atherosclerotic lesions remains a great challenge. To achieve targeted oxygen delivery to atherosclerotic plaques, Lipid 5-doped, platelet membrane-encapsulated magnetic mesoporous organosilicon nanoparticles loaded with perfluoro-15-crown ether (PFCE) (FMMON@PL) were prepared. PFCE worked as an oxygen carrier, while iron oxide nanoparticles (IONPs) acted as nanozymes with catalase-like activity to facilitate oxygen generation. To enhance plaque targeting, platelet membranes were coated onto mesoporous organosilicon nanoparticles containing PFCE and IONPs. Lipid 5 containing a tertiary amine was doped into the platelet membranes for lysosomal escape. Our results demonstrated that FMMON@PL specifically targeted macrophages in atherosclerotic plaques. FMMON@PL significantly reduced HIF-1α expression, ameliorated oxidative stress, inhibited foam cell formation, and reduced M1 macrophage polarization. In conclusion, FMMON@PL successfully achieved oxygen delivery within plaques and inhibited plaque progression, demonstrating the feasibility of hypoxia alleviation for the treatment of atherosclerosis.
BibTeX
@article{wang2025combining,
  author = {Yujie Wang and Qun Zhou and Le Lü and Jianhua Xu and Gang Yang and Xuan Sun and Xue Bao and Lina Kang and Pin Lv and Renyuan Liu and Biao Xu and Qi Yang and Dan Mu and Bing Zhang},
  title = {{Combining oxygen delivery and generation for targeted atherosclerosis therapy}},
  journal = {Journal of Controlled Release},
  year = {2025},
  doi = {10.1016/j.jconrel.2025.02.053},
}

Loading related content...

Figure